Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Sheep

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on May 21, 2024 10:36am

67 Views

Post# 36049873

RE:RE:RE:RE:RE:RE:RE:Sheep

by ENEMENEMYNEMOon May 05, 2022 6:15am

218 Views

Post# 34657688

RE:RE:Response from Investors Relations RVX

Ya but Christmas in what year??

I lost all faith in this company yesterday as IR has responded again to my initial email, this time it was in my Trash Box and was worded a little different.

Dog and Pony show here...looks like my Email Server is the only one in the know!

<< Previous

Bullboard Posts

Next >>

How to navigate the ups and downs of investing in AI